CervoMed
CRVO
24 hedge funds and large institutions have $7.27M invested in CervoMed in 2021 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 7 closing their positions.
29% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 7
9% more funds holding
Funds holding: 22 → 24 (+2)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more ownership
Funds ownership: 0.13% → 0.13% (+0%)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
20% less capital invested
Capital invested by funds: $9.11M → $7.27M (-$1.84M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$358K |
| 2 |
State Street
Boston,
Massachusetts
|
+$339K |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$111K |
| 4 |
VF
Virtu Financial
New York
|
+$97.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$76.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$331K |
| 2 |
Millennium Management
New York
|
-$307K |
| 3 |
BlackRock
New York
|
-$301K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$56K |
| 5 |
Two Sigma Advisers
New York
|
-$45K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Charles Schwab
San Francisco,
California
| – | -$41K | -590 | Closed |
|
|
HWA
27
HCR Wealth Advisors
Los Angeles,
California
| – | -$19K | -280 | Closed |
|
|
TRCT
28
Tower Research Capital (TRC)
New York
| – | -$5K | -77 | Closed |
|
29
Citigroup
New York
| – | -$3K | -44 | Closed |
|
30
Barclays
London,
United Kingdom
| – | -$1K | -8 | Closed |
|
31
Bank of America
Charlotte,
North Carolina
| – | +$55 | +1 | New |
|
CRVO Hedge Fund Activity: Q2 2021 in Review
24 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in CervoMed (CRVO) for Q2 2021, worth a combined $7.27M — down 20% from $9.11M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new CRVO positions and 7 closed out — a net gain of 2 holders — while 4 added to existing stakes and 5 trimmed.
The largest buyer was Vanguard Group, adding an estimated $358K. The largest seller was Renaissance Technologies, cutting an estimated $331K.
- 24 institutional investors held CervoMed (CRVO) as of Q2 2021, up from 22 in Q1 2021.
- Funds reported $7.27M of CervoMed stock for Q2 2021, down 20% quarter-over-quarter.
- 9 funds opened new CervoMed positions in Q2 2021 and 7 closed out, a net change of +2 holders.
- The largest CervoMed buyer in Q2 2021 was Vanguard Group, an estimated $358K added.
- The largest CervoMed seller in Q2 2021 was Renaissance Technologies, an estimated $331K sold.
Based on aggregated 13F filings for Q2 2021.